Do AI scribes help equally across patient languages? A 209,009-encounter study found uneven associations
Same-day note closure was 10.2 percentage points higher with an AI scribe in non-English language-concordant visits and 1.7 points higher in English visits after adjustment. Interpreter-mediated estimates were too imprecise for a conclusion, and the study did not test note accuracy or patient outcomes.
The short version
- What happened
- The peer-reviewed study analysed 209,009 in-person encounters involving 117,121 patients and 286 clinicians across 14 adult primary-care clinics; AI scribes were used in 47,743 encounters.
- Who it affects
- Clinicians may finish documentation sooner in some language-concordant visits, but health systems should not assume the same benefit in interpreter-mediated care.
- What remains unproven
- This was a retrospective cross-sectional study at one Boston academic health system using two products, limiting generalisability.
Keep in mind
This was a retrospective cross-sectional study at one Boston academic health system using two products, limiting generalisability.
Clinicians self-selected scribe access and encounter-level use; adjusted associations cannot establish causal effects.
Interpreter-mediated groups were small, producing wide confidence intervals and inconclusive estimates.
The dataset lacked product identity, adoption timing, visit duration, insurance status, detailed comorbidity measures and independent confirmation of language concordance.
Same-day note closure does not measure note accuracy, clinician workload, clinical decisions, patient experience or health outcomes.
Source analysis · 1 linked source. Primary analysed source date: 6 November 2026.
Read the full report · 8 min The evidence, methods, implications and limitations
The finding: faster note closure was not distributed evenly across communication settings
A peer-reviewed JAMA Network Open study published on 6 November found that ambient AI scribe use was associated with a higher probability of closing a primary-care note on the day of the visit, but the size and certainty of that association depended on how clinician and patient communicated. The strongest adjusted association appeared in visits where a patient preferred a language other than English and the clinician spoke that language: same-day closure was 10.2 percentage points higher with a scribe, with a 95% confidence interval from 7.4 to 12.9 points.
For English language-concordant visits, the adjusted association was much smaller at 1.7 percentage points, with a 95% confidence interval from 0.9 to 2.6 points. Estimates for visits involving video, telephone or in-person interpreters, or no documented interpreter despite nonconcordant language, were too imprecise for a firm conclusion. The study therefore does not support a claim that scribes improve documentation equally for everyone. It identifies a large association in one bilingual setting and an evidence gap precisely where conversations may involve multiple speakers, switching languages and more complex acoustics.[1]
What the 209,009-encounter denominator contains
The researchers analysed 209,009 in-person encounters from May 2025 through May 2026 at 14 adult primary-care clinics in one Boston academic medical centre. Those encounters involved 117,121 patients and 286 clinicians. AI scribes were used in 47,743 encounters and not used in 161,266. The study began four months after initial deployment so that the technology had time to spread through the system. Two scribe products were available, although the dataset did not identify which product was used in each encounter.
Most visits—193,035, or 92.4%—were English language-concordant. Another 9,638 were non-English language-concordant. The nonconcordant groups were far smaller: 1,076 encounters used a video interpreter, 2,182 a telephone interpreter, 734 an in-person interpreter and 2,344 had no interpreter documented. Those denominators explain why the interpreter estimates are uncertain. A system may contain hundreds of thousands of visits overall while still providing too few observations to estimate effects reliably for specific language-access workflows.[1]
The distinction that matters
What the study measured—and what it did not
The comparison links scribe use to one documentation outcome across six communication settings.
Exposure
Clinician chose whether to use an AI scribe
47,743 of 209,009 encounters
Outcome
Check whether the note was signed that day
Timeliness, not accuracy
Subgroups
Separate language and interpreter settings
Uneven, often imprecise estimates
Inference
Adjust observed differences statistically
Association, not causation
How the comparison was made—and why it cannot establish causation
Clinicians self-enrolled for scribe access on a rolling basis and decided whether to use the tool during each encounter. The exposure was identified from electronic health-record data. The outcome was narrow and operational: whether the clinician signed the note on the same calendar day as the visit. Communication type was recorded in the health record by clinicians, combining patient language preference, clinician language concordance and interpreter modality. It was not independently reassessed by the research team.
The authors used mixed-effects logistic regression with patient- and clinician-level random intercepts. The model adjusted for age, clinician type, clinical complexity, clinic setting and calendar time, and included an interaction between six communication categories and scribe use. Sensitivity checks used clinician fixed effects and within-clinician comparisons among clinicians who had both scribe and non-scribe encounters. Those analyses reduce some observable differences, but they cannot remove unmeasured selection. A clinician may choose a scribe for visits, patients or days that differ in ways the dataset did not capture.[1]
The unadjusted pattern was large in bilingual visits and modest in English visits
Before adjustment, 82.9% of non-English language-concordant encounters using a scribe had same-day closure, compared with 72.1% without one. English language-concordant encounters showed 80.0% with a scribe and 78.4% without. The adjusted estimates closely preserved the contrast between a roughly ten-point association in the bilingual group and a small association in the English group. The overall interaction across communication categories was statistically significant, indicating that one pooled average would hide meaningful variation.
That variation should not be interpreted as proof that the technology works better in every non-English language. The paper groups languages together and does not report product-specific performance, time since adoption or the duration of each visit. Only one of the two tools supported non-English, non-Spanish documentation without an interpreter, which may have influenced who used a scribe and when. Insurance status, detailed comorbidity measures, bilingual-patient classification and exact encounter timestamps were unavailable, leaving plausible residual differences between compared visits.[1]
Same-day closure matters, but it is not a measure of note quality or safer care
Closing notes promptly can reduce after-hours administrative work and make information available sooner for follow-up, referrals and other clinicians. It is therefore a useful operational outcome. But a note can be signed quickly and still contain omissions, transcription errors, incorrect speaker attribution or unsupported clinical statements. The study did not compare note accuracy, completeness, edits, diagnostic decisions, clinician attention during visits, patient understanding, follow-up care or health outcomes. It also did not measure whether the scribe reduced total documentation time.
Interpreter-mediated visits require particular care. Multiple speakers and language switching can challenge speech recognition and attribution, while a professional interpreter has a defined role that a documentation system should not obscure. The inconclusive results do not show that scribes harm those visits; they show that this dataset could not establish a clear association. Health systems should preserve interpreter services and evaluate scribe performance inside those workflows rather than assume that an efficiency gain measured in English or language-concordant care transfers automatically.[1]
What health systems can do now—and what evidence would change the assessment
A responsible deployment would monitor results by language, interpreter modality, clinic and product rather than publish one system-wide average. Hospitals should audit note accuracy and correction burden, ask patients and interpreters about the experience, and verify that consent and privacy information is understandable in the languages served. Bilingual workforce development and professional interpretation remain separate investments: an ambient scribe records a conversation; it does not replace the human communication needed to conduct the visit safely.
Confidence would rise with randomised or strong quasi-experimental studies that assign scribe access prospectively, identify the product and language, and measure note quality, clinician time, patient trust, clinical decisions and downstream outcomes. Larger multisite samples are needed for each interpreter modality. Evidence would weaken if apparent speed gains disappeared after accounting for adoption timing or if faster closure came with more corrections or clinically important errors. For now, the study shows an uneven association in one health system—not a universal efficiency effect or proof of equitable clinical benefit.[1]
Keep following the evidence
Join The Impact Brief founding list for selected AI reports, their effect on people and the evidence limits. Read a sample first.
Continue the story
Read next
Continue exploring clinical documentation: compare the finding and its evidence limits.
Did the AI write a better clinic note?
A prospective single-centre study of 62 adults with abdominal pain found that AI-generated notes were more complete than clinicians' notes but scored worse on factuality. The assistant also produced only 50% diagnostic accuracy in the prospective cohort, so the result supports supervised documentation research—not autonomous clinical use.
Read the next reportExplore the full source and evidence record
What this means for people
- Clinicians may finish documentation sooner in some language-concordant visits, but health systems should not assume the same benefit in interpreter-mediated care.
- Patients who prefer a language other than English need both accurate documentation and effective communication; a scribe cannot replace a professional interpreter or bilingual clinician.
- Interpreters and clinic teams should be involved in product testing because speaker attribution, language switching, privacy and correction work can alter both safety and workload.
Global context
Ambient documentation tools are spreading through health systems faster than evidence about language access. Large English-dominant datasets can make an average efficiency result look precise while leaving bilingual and interpreter-mediated care underpowered. That matters internationally because language diversity, interpreter availability, privacy rules, clinical workflows and product support differ across countries. The study provides a useful subgroup framework, but its Boston results should be tested locally before hospitals use them to justify workforce, procurement or equity claims.
What the evidence does not yet show
- This was a retrospective cross-sectional study at one Boston academic health system using two products, limiting generalisability.
- Clinicians self-selected scribe access and encounter-level use; adjusted associations cannot establish causal effects.
- Interpreter-mediated groups were small, producing wide confidence intervals and inconclusive estimates.
- The dataset lacked product identity, adoption timing, visit duration, insurance status, detailed comorbidity measures and independent confirmation of language concordance.
- Same-day note closure does not measure note accuracy, clinician workload, clinical decisions, patient experience or health outcomes.
What to watch next
- Prospective or randomised comparisons with product identity and time since adoption recorded.
- Note-accuracy, correction-burden and patient-safety outcomes by language and interpreter modality.
- Larger multisite samples for video, telephone and in-person interpreted visits.
- Patient, interpreter and clinician experience, including privacy and consent in supported languages.
- Evidence that faster documentation translates into less after-hours work or better continuity without increasing errors.
Living evidence record
Impact record IAI-0O7RAQI
Evidence stage
Studied
Confidence
Supported
Reporting basis
Source analysis
Independent or research support
Present
Record status
Monitoring
Last checked
7 November 2026
Source trail
1 direct source across 1 source type.
People impact
Documented in this record.
Uncertainty
Limits and next checks are explicit.
Stages describe the evidence available—not whether a technology is good or bad. See the public method.
Single-source reporting disclosure
This record analyses one direct source. It can establish what JAMA Network Open published or reported, but it is not independent corroboration of every performance claim or predicted outcome. The confidence label will change only when broader evidence is added.
Evidence trail
Sources used for this report
Links checked 7 November 2026
Research question, topics and regions
Whether use of ambient AI scribes is associated with same-day note closure across language-concordant and interpreter-mediated primary-care encounters
Topics: Ambient AI scribes · Primary care · Language access · Clinical documentation · Health equity
Regions: United States · Global
This report is labelled source analysis. We summarise and analyse source material in our own words; company statements remain attributed claims until independently supported. Translated summaries preserve the meaning of the original source and link back to it. Read our editorial standards.
Reader commentary
What does this mean where you are?
Tell us what you have seen at work, in your community or in everyday life. A question is welcome too. No account is needed; we review notes before publishing them.
Explore commentary across the portal →Published reader notes
0No published reader notes yet. You can start the evidence-led discussion above.
Prefer a private correction or response? Contact the newsroom.